Ascendis Pharma A/S

Ascendis Pharma is a prominent biotech company situated in Copenhagen, Denmark, with the goal of improving patients' lives through innovative medicine development. Since its establishment in 2007, the company has quickly grown to become a major player in the biotech industry, with operations in the United States and Germany.

Ascendis Pharma's staff is motivated by a genuine desire to make a major difference in the lives of patients. They plan to achieve this through producing best-in-class medicines that address unmet medical requirements while also improving patient outcomes. The company specializes on endocrine and metabolic diseases, and their TransCon technology platform allows for the development of long-acting prodrug therapies with sustained and consistent dosing.

Ascendis Pharma's commitment to innovation and quality has been recognized through numerous accolades and industry recognition. The company offers a robust pipeline of drug candidates in various stages of development, including treatments for growth hormone deficiency, achondroplasia, and hypoparathyroidism.

Ascendis Pharma is a leading biotech company that is reshaping the healthcare industry. Its dedication to improving patient outcomes, as well as its distinct approach to drug development, have established it as a notable leader in the biotech business, with a promising future.

Founded: 2007

Headquarters: Hellerup, Denmark

Website: https://ascendispharma.com